'Little things' blossomed into big QA trouble at J&J/McNeil

"When they leave, they take the routine with them," said an anonymous former J&J/McNeil worker of QA staff reductions following the company's acquisition of Pfizer Consumer Healthcare in 2006. "It can be a couple of little things that are let go and turn into problems, like machine parts wearing out." An investigation into metal particle contamination of Infants' Tylenol from the company's Fort Washington, PA, plant cited metal-on-metal wear of pistons in bottling-line equipment as the probable source. The plant, voluntarily closed in April 2010 and now under consent decree with the FDA, is undergoing a $100 million remediation. Story

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.